Ting Yi MD, Xiaojuan Guo PhD, Yanbin Fang MM, Hanwei Liang MM, Yang Lu PhD, Xiaolu Zhang MM, Han Cao PhD, Jinzhe Liu PhD, Qiyue Wang MM, Youge Qu PhD, Xuan Jiang MD
{"title":"Effects of Unilateral and Bilateral Sacral Nerve Stimulation on Defecation and Microbiota in Constipated Dogs","authors":"Ting Yi MD, Xiaojuan Guo PhD, Yanbin Fang MM, Hanwei Liang MM, Yang Lu PhD, Xiaolu Zhang MM, Han Cao PhD, Jinzhe Liu PhD, Qiyue Wang MM, Youge Qu PhD, Xuan Jiang MD","doi":"10.1016/j.neurom.2025.10.065","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>This study aims to explore potential differences in therapeutic efficacy and impact on intestinal microbiota between unilateral and bilateral sacral nerve stimulation (uSNS and bSNS) in the treatment of constipation.</div></div><div><h3>Materials and Methods</h3><div>Dual-channel sacral nerve stimulators were implanted in six beagles, while constipation was induced using compound diphenoxylate and alosetron hydrochloride. Using a randomized crossover design, dogs (total n = 6) underwent uSNS and bSNS interventions sequentially, with ten-day washout periods. Data collection spanned four stages: baseline, constipation, uSNS treatment, and bSNS treatment. Measured parameters included the number of defecations, Bristol Stool Form Scale (BSFS) scores, total gastrointestinal transit time (TGTT), short-chain fatty acid concentrations (quantified via liquid chromatography–tandem mass spectrometry), and intestinal microbiota levels (assessed by 16S ribosomal RNA [rRNA] V3–V4 region sequencing).</div></div><div><h3>Results</h3><div>Compared with the baseline stage, the constipation stage showed a reduced number of defecations, lower BSFS scores, and prolonged TGTT (<em>p</em> < 0.05). Sacral nerve stimulation (SNS) improved BSFS scores and shortened TGTT in constipated dogs, but only bSNS showed statistically significant changes relative to the constipation stage (<em>p</em> < 0.05). Moreover, bSNS shortened TGTT significantly more than uSNS (<em>p</em> < 0.05). 16S rRNA sequencing revealed that constipation altered the intestinal microbiota composition. In constipated dogs, <em>Blautia</em> abundance and the concentrations of butyrate and valerate were lower than those at baseline (<em>p</em> < 0.05). After SNS treatment, these measures increased without reaching statistical significance (<em>p</em> > 0.05).</div></div><div><h3>Conclusions</h3><div>bSNS improved BSFS scores and TGTT in constipated dogs and was superior to uSNS for TGTT. SNS may also beneficially modulate intestinal microbiota, which warrants confirmation in larger studies.</div></div>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":"29 7","pages":"Pages 1155-1165"},"PeriodicalIF":3.7000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuromodulation","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1094715925011407","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/4 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
This study aims to explore potential differences in therapeutic efficacy and impact on intestinal microbiota between unilateral and bilateral sacral nerve stimulation (uSNS and bSNS) in the treatment of constipation.
Materials and Methods
Dual-channel sacral nerve stimulators were implanted in six beagles, while constipation was induced using compound diphenoxylate and alosetron hydrochloride. Using a randomized crossover design, dogs (total n = 6) underwent uSNS and bSNS interventions sequentially, with ten-day washout periods. Data collection spanned four stages: baseline, constipation, uSNS treatment, and bSNS treatment. Measured parameters included the number of defecations, Bristol Stool Form Scale (BSFS) scores, total gastrointestinal transit time (TGTT), short-chain fatty acid concentrations (quantified via liquid chromatography–tandem mass spectrometry), and intestinal microbiota levels (assessed by 16S ribosomal RNA [rRNA] V3–V4 region sequencing).
Results
Compared with the baseline stage, the constipation stage showed a reduced number of defecations, lower BSFS scores, and prolonged TGTT (p < 0.05). Sacral nerve stimulation (SNS) improved BSFS scores and shortened TGTT in constipated dogs, but only bSNS showed statistically significant changes relative to the constipation stage (p < 0.05). Moreover, bSNS shortened TGTT significantly more than uSNS (p < 0.05). 16S rRNA sequencing revealed that constipation altered the intestinal microbiota composition. In constipated dogs, Blautia abundance and the concentrations of butyrate and valerate were lower than those at baseline (p < 0.05). After SNS treatment, these measures increased without reaching statistical significance (p > 0.05).
Conclusions
bSNS improved BSFS scores and TGTT in constipated dogs and was superior to uSNS for TGTT. SNS may also beneficially modulate intestinal microbiota, which warrants confirmation in larger studies.
期刊介绍:
Neuromodulation: Technology at the Neural Interface is the preeminent journal in the area of neuromodulation, providing our readership with the state of the art clinical, translational, and basic science research in the field. For clinicians, engineers, scientists and members of the biotechnology industry alike, Neuromodulation provides timely and rigorously peer-reviewed articles on the technology, science, and clinical application of devices that interface with the nervous system to treat disease and improve function.